Home
Our Business
About
Mission & Heritage
Values
Management
Facilities
News & Announcements
Innovation
Analytical
Generic Research
Intellectual Property
New Drug Discovery
Opportunities
Markets
India
International
Investors
Financials
financials
Subsidiary Accounts
Share Monitor
Shareholder Information
Shareholding Pattern
Investor Service Request Form
Investor Presentation
Statutory Communications
Scheme of Amalgamation
Unclaimed Dividend
Investors Education Protection Fund (IEPF)
Buy back
Buy back 2018
Buy back 2023
PAPER ADVERTISEMENTS
Board Meeting Intimations
ANNUAL SECRETARIAL COMPLIANCE CERTIFICATE
CREDIT RATINGS
Annual Reports
Annual Return
AGM
Impact Assessment Report
Corporate Governance & Policies
Corporate Governance Certificate
IR AND SHAREHOLDER CONTACTS
INVESTOR RELATIONS
FOR GRIEVANCE REDRESSAL
QIP 2017
People
Meet Our People
Careers
Responsibility
CSR Policy
Environment, Health & Safety
Attivaram
Chemical unit-Mekaguda
Chemical Unit-Chennai
Certification & Awards
Natco Trust
Business Responsibility Policies
Sustainability Report
ESG PROFILE
Contact
Locations
Contact us
Our growth story has only just begun. We endeavour to mitigate risk for investors and encourage transparency in all our dealings
Statutory Communications
Intimation of Change in Management 03.04.2025
Intimation of Change in Management 31-03-2025.
Intimation of Change in Management 03.03.2025
Intimation of Change in Management 27.02.2025
Investor Meeting 04-03-2025
Investor Meeting 28-02-2025
Intimation of Change in Management 12.02.2025
Outcome of Board Meeting 12.02.2025
Revised Q3FY25 CONCALL INTIMATION
Intimation under Regulation 30 - Approval of Abbreviated New Drug Application (ANDA) for Bosentan Tablets for Oral Suspension (generic of Tracleer®)
Q3FY25 CONCALL INTIMATION
Intimation under Regulation 30 - Approval of Abbreviated New Drug Application (ANDA) for Everolimus tablets for Oral Suspension (generic of AFINITOR DISPERZ®)
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Appointment of Senior Management
Revised Record Date
Outcome of Board Meeting 12.11.2024
Intimation of Appointment of Senior Management
Q2FY25 CONCALL INTIMATION
Intimation of Appointment of Senior Management
Intimation of Resignation of Senior Management
Investor Meeting 20-09-2024
Investor Meeting 19-09-2024
Investor Meeting 11-09-2024
Investor Meeting 05-09-2024
Investor Meeting 02-09-2024
Intimation of Change in Management 12.08.2024
Outcome of Board Meeting 12.08.2024
Investor Meeting 14.08.2024
Q1FY25 CONCALL INTIMATION
Intimation of Demise of Independent Director of the Company
Intimation of Resignation of Senior Management
Investor Meeting 04.07.2024
Intimation of Appointment of Senior Management
Investor Meeting 10.06.2024
Investor Meeting 30.05.2024
Investor Meeting 29.05.2024
Q4FY2024 CONCALL INTIMATION
Investor Meeting 22.04.2024
Postal Ballot Voting results
Investor Meeting 06.03.2024
Intimation of Resignation of Senior Management
Investor Meeting 28.02.2024
Notice of Postal Ballot - 2024
Outcome of Board Meeting 14.02.2024
Q3FY24 CCONCALL INTIMATION
Investor Meeting 15.12.2023
Intimation of Resignation of Senior Management
Outcome of Board Meeting 14.11.2023
Q2FY2024 CONCALL INTIMATION
Q1FY2024 CONCALL INTIMATION
Trading window intimation - 29.06.2023
Q4FY2023 CONCALL INTIMATION
Outcome of Board Meeting 20.04.2023
Trading window intimation
Postal Ballot Voting results
Paper Publication of Postal Ballot Notice
Notice of Postal Ballot - 2022
Annual Return 2020-21
Familiarisation program for Independent Directors
36th AGM Voting Results
Letter of Appointment for Independent directors
Postal Ballot Scrutinizers Report
Postal Ballot Results
Contact information of KMP
MOA & AOA
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
Privacy policy
